Cargando…
Prolonged Response of Metastatic Programmed Death-Ligand 1 (PD-L1) Negative Basaloid Squamous Cell Carcinoma of the Lung to Maintenance Immunotherapy
Basaloid squamous cell carcinoma (BSCC) is a variant of squamous cell carcinoma that is most often seen as a variety of primary head and neck cancers. BSCC of the lung is rare primary lung cancer and an uncommon histological subtype of non-small cell lung carcinoma. Due to its rarity, there is littl...
Autores principales: | Fox, Ashley D, Ullah, Asad, Vemavarapu, Lakshmi K, Bustamante, Freyli, Abdel Karim, Nagla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126477/ https://www.ncbi.nlm.nih.gov/pubmed/35619841 http://dx.doi.org/10.7759/cureus.24396 |
Ejemplares similares
-
Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?
por: Chiruvella, Varsha, et al.
Publicado: (2022) -
Primary Neurosarcoidosis Mimicking Gallbladder Pathology
por: ULLAH, ASAD, et al.
Publicado: (2021) -
Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022) -
Prognostic utility of basaloid differentiation in oropharyngeal cancer
por: Cooper, Timothy, et al.
Publicado: (2013) -
Metastatic Malignant Peripheral Nerve Sheath Tumor (MPNST) in Neurofibromatosis Type 1: Challenges in Diagnosis and Management
por: Pulliam, Steven, et al.
Publicado: (2022)